摘要: Estrogen has been shown to increase the expression and activity of amyloid peptide inactivating enzymes in brain. Peptides have an enzyme. Methods identifying compounds for, methods treating patients with, Alzheimer's Disease is disclosed.
lens.org 参考文章(9)
Christopher B. Eckman, Elizabeth A. Eckman, ENDOTHELIN CONVERTING ENZYMES AND THE AMYLOID βPEPTIDE ,(2001)
Roger Nitsch, Johannes Pohlner, Hasan Mohajeri, Axel Wollmer, Methods and compounds for treating brain amyloidosis ,(2001)
Robert K. K. Lee, Richard J. Wurtman, Regulation of amyloid precursor protein (APP) expression by administration of an estrogenic compound ,(1998)
Gerhard Breipohl, Klaus Wirth, Stephan Henke, Holger Heitsch, Jochen Knolle, Gabriele Wiemer, Use of non-peptide bradykinin antagonists for the treatment or prevention of Alzheimer's disease ,(1997)
S.L. Wagner, R.E. Tanzi, R.D. Moir, Clearance of Alzheimer's Aβ Peptide: The Many Roads to Perdition Neuron. ,vol. 43, pp. 605- 608 ,(2004) , 10.1016/J.NEURON.2004.08.024
M. Hasan Mohajeri, M. Axel Wollmer, Roger M. Nitsch, Aβ42-induced Increase in Neprilysin Is Associated with Prevention of Amyloid Plaque Formation in Vivo Journal of Biological Chemistry. ,vol. 277, pp. 35460- 35465 ,(2002) , 10.1074/JBC.M202899200
Nicholas S. Bodor, Brain-enhanced delivery of neuroactive peptides by sequential metabolism ,(1993)
Chaovanee Aroonsakul, Treating central nervous system diseases ,(1989)
James W. Simpkins, Jean Bishop, Meharvan Singh, Methods for neuroprotection ,(1994)